Core Insights - Rubicon Organics Inc. reported record-breaking financial results for Q2 2025, achieving net revenue of $15.0 million, a 24% increase year-over-year, and a year-to-date (YTD) net revenue of $27.4 million, reflecting a 30% increase compared to the same period last year [3][8][9] Financial Performance - The company generated Adjusted EBITDA of $1.4 million for Q2 2025 and $2.1 million for the first half of 2025, marking positive Adjusted EBITDA for five consecutive quarters [3][9] - Operating profit reached $1.0 million for Q2 2025, with a net profit of $0.8 million, compared to a net loss of $0.5 million in the same quarter of the previous year [3][21] - Gross profit before fair value adjustments was $5.1 million for Q2 2025, with a gross profit margin of 34.2%, up from 30.2% in Q2 2024 [21] Production and Capacity Expansion - The acquisition of the Hope Facility was completed, increasing total production capacity by over 40%, bringing the total annual capacity to 15,500 kg of premium cannabis [8][12] - The Delta Facility is fully operational with an annual production capacity of 11,000 kg, and the company is focused on improving yield and quality [11][12] Market Position and Brand Strategy - Rubicon Organics holds a national market share of 5.2% in premium flower and pre-rolls, 15.1% in resin vapes, and 26.2% in premium edibles [9] - The company emphasizes its commitment to quality and innovation, with a focus on expanding its genetic portfolio and launching new products under its trusted brands [6][18] Future Outlook - The company anticipates continued growth in net revenue and Adjusted EBITDA for 2025, despite expected one-time costs associated with the Hope Facility [20] - Rubicon Organics aims to meet increasing domestic and international demand for premium cannabis while maintaining its focus on brand loyalty and consumer trust [10][14]

Core Viewpoint - Rubicon Organics Inc. is set to release its financial results for Q2 2025 on August 18, 2025, and will host a conference call to discuss these results, highlighting its position as a leader in the organic and premium cannabis market in Canada [1][2]. Company Overview - Rubicon Organics is a licensed producer focused on cultivating and selling organic certified and premium cannabis products, with a vertically integrated model and strong national distribution [2]. - The company operates under trusted brands such as Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™, and Homestead Cannabis Supply™ [2]. Production Capacity and Facilities - The company's production base is anchored by its Delta, BC Facility, complemented by the acquisition of the Hope, BC Facility, which will expand production capacity by over 40% [3]. - This expansion supports future growth in both domestic and export markets, positioning Rubicon at the forefront of the premium cannabis segment [3]. Market Position and Strategy - As the Canadian market rationalizes and global demand for high-quality cannabis increases, Rubicon's disciplined execution, brand equity, and consumer loyalty differentiate it from competitors [4]. - The company's focus on premium quality, innovation, and operational execution has led to consistent revenue growth and positive Adjusted EBITDA [4]. - Rubicon Organics represents a combination of category leadership, operational strength, and long-term growth potential [4].

Core Viewpoint - Rubicon Organics Inc. is set to hold its Annual General and Special Meeting on July 31, 2025, to discuss various corporate matters including financial statements and director elections [1][2]. Company Overview - Rubicon Organics is a leading Canadian producer of certified organic and premium cannabis, with a vertically integrated model and a strong national distribution network [4]. - The company is scaling trusted brands such as Simply Bare™ Organics and 1964 Supply Co.™, supported by its Delta, BC Facility and the newly acquired Hope, BC Facility, which will increase production capacity by over 40% [5]. Financial and Operational Highlights - The company has demonstrated consistent revenue growth and positive Adjusted EBITDA, driven by a focus on premium quality, innovation, and operational execution [6]. - Rubicon Organics is positioned to capitalize on the increasing global demand for high-quality cannabis, distinguishing itself through brand equity and consumer loyalty [6]. Meeting Agenda - The Meeting will cover the following key items: 1. Review of audited financial statements for the year ended December 31, 2024 [8]. 2. Setting the number of directors at eight [8]. 3. Election of directors for the upcoming year [8]. 4. Appointment of PricewaterhouseCoopers LLP as auditors and authorization for directors to fix their remuneration [8]. 5. Consideration of an amendment to the Omnibus Equity Incentive Plan to reserve 8,960,179 Common Shares for issuance [8]. 6. Discussion of any other business that may properly come before the Meeting [8].